Warning! GuruFocus detected
2 Severe warning signs
with SCD.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Zentiva SA
SIC : 2834
ISIN : ROSCDBACNOR8
Compare
Compare
Traded in other countries / regions
SCD.Romania0I6N.UK IPO Date
1998-08-13Description
Zentiva SA is a Romania-based producer of medicines on the local market. The product portfolio of Zentiva SA includes more than 126 products for human use, such as solids (tablets, capsules, and pellets), generic products, and injectable solutions. The company provides products for therapeutic areas such as Cardiovascular diseases, Anti-inflammatory and pain-relieving medications, urologists, Blood diseases, Gastrointestinal and metabolic disorders, Central nervous system, Medicines against infections, and Diseases of the respiratory system.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.82 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Interest Coverage | 52.86 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 9.53 | |||||
| Beneish M-Score | -1.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.1 | |||||
| 3-Year EBITDA Growth Rate | 29.9 | |||||
| 3-Year EPS without NRI Growth Rate | 34.2 | |||||
| 3-Year FCF Growth Rate | -40 | |||||
| 3-Year Book Growth Rate | 17.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 77.09 | |||||
| 14-Day RSI | 71.21 | |||||
| 6-1 Month Momentum % | 11.88 | |||||
| 12-1 Month Momentum % | 47.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.45 | |||||
| Quick Ratio | 4.72 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 155.47 | |||||
| Days Sales Outstanding | 167.19 | |||||
| Days Payable | 179.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.01 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.63 | |||||
| Operating Margin % | 22.37 | |||||
| Net Margin % | 23.23 | |||||
| FCF Margin % | 3.26 | |||||
| ROE % | 19.5 | |||||
| ROA % | 15.72 | |||||
| ROIC % | 16.6 | |||||
| 3-Year ROIIC % | 17.98 | |||||
| ROC (Joel Greenblatt) % | 42.9 | |||||
| ROCE % | 21.59 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.25 | |||||
| PE Ratio without NRI | 11.74 | |||||
| Shiller PE Ratio | 22.45 | |||||
| Price-to-Owner-Earnings | 29.16 | |||||
| PEG Ratio | 0.41 | |||||
| PS Ratio | 2.84 | |||||
| PB Ratio | 2.17 | |||||
| Price-to-Tangible-Book | 2.22 | |||||
| Price-to-Free-Cash-Flow | 86.92 | |||||
| Price-to-Operating-Cash-Flow | 35.87 | |||||
| EV-to-EBIT | 10.78 | |||||
| EV-to-EBITDA | 9.74 | |||||
| EV-to-Revenue | 2.83 | |||||
| EV-to-FCF | 86.67 | |||||
| Price-to-GF-Value | 1.33 | |||||
| Price-to-Projected-FCF | 2.18 | |||||
| Price-to-DCF (Earnings Based) | 0.62 | |||||
| Price-to-DCF (FCF Based) | 7.53 | |||||
| Price-to-Median-PS-Value | 1.19 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.47 | |||||
| Price-to-Graham-Number | 1.08 | |||||
| Price-to-Net-Current-Asset-Value | 2.74 | |||||
| Earnings Yield (Greenblatt) % | 9.28 | |||||
| FCF Yield % | 1.15 | |||||
| Forward Rate of Return (Yacktman) % | 21.22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zentiva SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil lei) | 1,113.845 | ||
| EPS (TTM) (lei) | 0.369 | ||
| Beta | 0.56 | ||
| 3-Year Sharpe Ratio | 1.01 | ||
| 3-Year Sortino Ratio | 2.65 | ||
| Volatility % | 26.43 | ||
| 14-Day RSI | 71.21 | ||
| 14-Day ATR (lei) | 0.000139 | ||
| 20-Day SMA (lei) | 4.52 | ||
| 12-1 Month Momentum % | 47.71 | ||
| 52-Week Range (lei) | 2.9 - 4.6 | ||
| Shares Outstanding (Mil) | 697.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zentiva SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zentiva SA Stock Events
| Event | Date | Price (lei) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zentiva SA Frequently Asked Questions
What is Zentiva SA(BSE:SCD)'s stock price today?
The current price of BSE:SCD is lei4.52. The 52 week high of BSE:SCD is lei4.60 and 52 week low is lei2.90.
When is next earnings date of Zentiva SA(BSE:SCD)?
The next earnings date of Zentiva SA(BSE:SCD) is .
Does Zentiva SA(BSE:SCD) pay dividends? If so, how much?
Zentiva SA(BSE:SCD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers